Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 14, Issue 12, Pages 1452-1464
Publisher
Oxford University Press (OUP)
Online
2012-11-07
DOI
10.1093/neuonc/nos270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic Gliomas
- (2011) Benito Campos et al. AMERICAN JOURNAL OF PATHOLOGY
- Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production
- (2011) Claudia R. Oliva et al. PLoS One
- Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis
- (2010) Roberto Pallini et al. CANCER
- Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres
- (2010) Alicia M. Mihaliak et al. CANCER LETTERS
- MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
- (2010) N. Gaspar et al. CANCER RESEARCH
- Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
- (2010) B. Campos et al. CLINICAL CANCER RESEARCH
- Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition
- (2010) Wen-bin Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
- (2010) M. Rasper et al. NEURO-ONCOLOGY
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
- (2009) S. Nobusawa et al. CLINICAL CANCER RESEARCH
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
- (2009) G. Frosina MOLECULAR CANCER RESEARCH
- Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
- (2008) D. Beier et al. CANCER RESEARCH
- Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
- (2008) J. N. Sarkaria et al. CLINICAL CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
- (2008) Satori A Marchitti et al. Expert Opinion on Drug Metabolism & Toxicology
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples
- (2008) Marcus Bettstetter et al. LABORATORY INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started